November 13, 2014

Pharmacists can make use of a suite of resources on Ebola virus specifically designed for those who work in the community sector as of Thursday.

November 13, 2014

 Janssen Pharmaceuticals announced that the Food and Drug Administration approved the company's supplemental new drug application for the once-monthly Invega Sustenna (paliperidone palmitate), an antipsychotic used to treat schizoaffective disorder as either monotherapy or adjunctive therapy. 

November 13, 2014

A new analysis released by Avalere Health Thursday found that Medicare Part D prescription drug plans are poised to increase significantly the use of coinsurance in 2015. 

November 13, 2014

Rite Aid on Thursday announced that RediClinic CEO Web Golinkin will assume additional responsibilities as the CEO of Health Dialog.

 

November 12, 2014

Drug Store News caught up with Rite Aid's Robert Thompson to discuss the impact Vaccine Central will have on raising immunization awareness. 

 

November 11, 2014

Dr. Reddy's Labs received approval from the Food and Drug Administration for a generic version of Roche Holding's antiviral medication Valcyte, according to a Reuters report

November 11, 2014

Rite Aid officially named Physician Direct ACO, based in Sylvan Lake, Mich., as the sixth healthcare provider to join its Rite Aid Health Alliance initiative.

 

November 11, 2014

Teva Pharmaceuticals announced the introduction of dexmethylphenidate hydrochloride extended-release capsules, CII, in a 5-mg strength.

November 11, 2014

UCB, Advent International and Avista Capital Partners last week announced they have entered into a definitive agreement providing for the acquisition of UCB’s U.S. specialty generics subsidiary, Kremers Urban Pharmaceuticals, by Advent and Avista.

November 11, 2014

Upsher-Smith has announced the release of the second in a series of educational e-books created for independent community pharmacists, The Front-End Opportunity: Capitalizing on the Highly Profitable Front-End.

November 10, 2014

Eli Lilly and Co. on Monday announced that its Type 2 diabetes treatment drug Trulicity (dulaglutide) , is now available in U.S. pharmacies. The drug is a once-weekly glucagon-like peptide-1 receptor agonist, and comes in a single-dose pen, which doesn't require the patient to mix, measure or handle the needle, the company said.

November 10, 2014

Greenstone announced the launch of sirolimus tablets. The product is offered in 1-mg and 2-mg dosage strengths in bottles of 100 tablets each. 

November 10, 2014

Health Mart on Monday announced that it is hosting its second series of Town Hall meetings, “Pharmacy Quality Measures: Action Steps for Improvement.”

November 10, 2014

The National Association of Chain Drug Stores has bolstered its pharmacy care and patient advocacy department with the hiring of Sara Rubin, who has joined NACDS as manager, pharmacy care. Rubin reports to Alex Adams, VP, pharmacy programs.

November 10, 2014

A national survey from Rite Aid and National Foundation for Infectious Diseases released Monday found that the majority of adult women living in the United States do not believe they are up to date on vaccinations to protect against many preventable diseases. 

November 10, 2014

The Saint Francis FastCare in-store health clinic has opened inside Super Stop & Shop supermarket in Simsbury, marking the first in-store primary care clinic of its kind in a supermarket in Central Connecticut.

November 10, 2014

Sandoz last week announced the launch of a generic version of cyclophosphamide injection, USP. Sandoz is launching the drug through collaboration with Jiangsu Hengrui Medicine Co., which owns the product's abbreviated new drug application. 

November 7, 2014
Don't google it, check a reliable source. That's the advice a Belgian healthcare website, Gezondheid en Wetenschap, recently advertised in this YouTube video that you have to play to believe. Sadly, they need to advertise such advice. Because do you know what is notably absent in the country? A pharmacist. 
November 7, 2014

The National Pharmaceutical Council on Friday announced that David Martin, SVP market access and commercial services for Eisai, has been named chairman of NPC's board of directors for 2014-15.

November 7, 2014

Janssen Therapeutics announced earlier this week that the Food and Drug Administration approved Olysio (simeprevir), a hepatitis C virus NS3/4A protease inhibitor, in combination with sofosbuvir as an all-oral, interferon- and ribavirin-free treatment option for genotype 1 chronic hepatitis C (CHC) infection in adult patients as part of a combination antiviral treatment regimen. 

November 7, 2014

Canada Health Infoway and McKesson Canada announced Thursday that RelayHealth has achieved Infoway's Category II Uni-Directional Consumer Health Application certification.

November 7, 2014

Mylan on Friday announced that it has signed an agreement with Walt Disney Parks and Resorts to help increase awareness of anaphylaxis, a severe allergic reaction. 

November 7, 2014

Teva Pharmaceutical on Friday announced positive findings from a Phase III clinical study that examined the safety and efficacy of Qnasl.

November 7, 2014

Walgreens on Thursday announced that its wholly owned subsidiary, Walgreens Boots Alliance has priced an underwritten public offering of unsecured, unsubordinated notes.